FDA approves fibrinogen concentrate product.
Thompson
Cheryl A
CA
D000347:Afibrinogenemia / Q000150:complications / Q000188:drug therapy*; D017277:Drug Approval; D005340:Fibrinogen / Q000009:adverse effects / Q000627:therapeutic use*; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D005340:Fibrinogen